To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement

• Status: Recruiting
• Trial end date: 2022-08-12
• Target enrollment: 0
• Participant gender: All

Summary

The supplementation of hydrogen molecules as an aid, adjuvant, may speed up recovering the course of the disease. The purpose of this study is to determine the safety and possible efficacy of hydrogen supplements in different formula and dose exposures for a clinical study in rheumatologic patients. Patients will receive a different dosage of either hydrogen capsules, hydrogen gas or hydrogen-rich water with their conventional treatment for a month. Investigators will test for any changes in haematologic, urine analysis and health status during and following the exposure period.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: HoHo Biotech
• Collaborator: Tri-Service General Hospital

Criteria

Inclusion Criteria:

• Age 20 to 80

• Able to compliant with the protocol

• Able to return to the hospital regularly

Exclusion Criteria:

• Pregnancy

• Expected pregnancy